Castle Biosciences SG&A Expense (TTM) Trends

Castle Biosciences Inc (CSTL)

27.86 -0.14 (-0.50%) USD | NASDAQ | Sep 27, 16:00

27.85 -0.01 (-0.04%) Pre-Market: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
June 30, 2024	188.29M
March 31, 2024	181.88M
December 31, 2023	180.15M
September 30, 2023	174.49M
June 30, 2023	166.50M
March 31, 2023	159.31M
December 31, 2022	143.00M
September 30, 2022	129.74M
June 30, 2022	115.71M
March 31, 2022	99.03M
December 31, 2021	86.74M
September 30, 2021	76.54M

Date	Value
June 30, 2021	65.64M
March 31, 2021	55.22M
December 31, 2020	48.13M
September 30, 2020	43.02M
June 30, 2020	38.44M
March 31, 2020	34.87M
December 31, 2019	29.84M
September 30, 2019	24.16M
June 30, 2019	20.95M
March 31, 2019	18.29M
December 31, 2018	16.47M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

24.16M

Minimum

Sep 2019

188.29M

Maximum

Jun 2024

102.04M

Average

92.88M

Median

SG&A Expense (TTM) Benchmarks